Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026)

Zoetis (ZTS) reported Depreciation & Amortization (CF) of $119.0 million for Q1 2026, little changed year-over-year from $119.0 million in Q1 2025, and down 1.65% quarter-over-quarter from $121.0 million in Q4 2025.

Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $119.0 million in Q1 2026.

  • Depreciation & Amortization (CF) for Q1 2026 came in at $119.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $487.0 million (down 0.61% YoY), and the FY2025 annual result was $487.0 million, down 2.01% from the prior year.
  • Depreciation & Amortization (CF) slipped to $119.0 million in Q1 2026 per ZTS's latest filing, from $121.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $127.0 million in Q2 2024 and troughed at $114.0 million in Q1 2022.
  • A 5-year average of $121.1 million and a median of $121.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) advanced 7.83% in 2023, then dropped 5.56% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $119.0 million in 2022, then gained by 5.88% to $126.0 million in 2023, then dropped by 2.38% to $123.0 million in 2024, then decreased by 1.63% to $121.0 million in 2025, then dropped by 1.65% to $119.0 million in 2026.
  • Business Quant data shows ZTS's Depreciation & Amortization (CF) at $119.0 million in Q1 2026, $121.0 million in Q4 2025, and $124.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 239.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 19.43 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 22.68 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 21.95 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 497,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 119.00 Mn
Mar 31, 2026 119.00 Mn
Dec 31, 2025 121.00 Mn
Dec 31, 2025 121.00 Mn
Sep 30, 2025 124.00 Mn
Sep 30, 2025 124.00 Mn
Jun 30, 2025 123.00 Mn
Jun 30, 2025 123.00 Mn
Mar 31, 2025 119.00 Mn
Mar 31, 2025 119.00 Mn
Dec 31, 2024 123.00 Mn
Dec 31, 2024 123.00 Mn
Sep 30, 2024 121.00 Mn
Sep 30, 2024 121.00 Mn
Jun 30, 2024 127.00 Mn
Jun 30, 2024 127.00 Mn
Mar 31, 2024 126.00 Mn
Mar 31, 2024 126.00 Mn
Dec 31, 2023 126.00 Mn
Dec 31, 2023 126.00 Mn